Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Brexit

- PMLiVE

Pfizer/BioNTech’s KP.2-adapted COVID-19 vaccine receives CHMP recommendation

The updated vaccine was shown to generate an improved response against currently circulating variants

- PMLiVE

Sanofi/Regeneron’s Dupixent approved by MHRA to treat uncontrolled COPD

Approximately 1.4 million people in the UK have been diagnosed with the respiratory disease

- PMLiVE

MHRA authorises first in new class of treatment for endometriosis symptoms

The chronic condition affects approximately 176 million women worldwide

- PMLiVE

Moderna’s JN.1-adapted COVID-19 vaccine approved by MHRA for adults and children

The JCVI has already advised the UK government on eligible groups for this year’s autumn vaccination programme

Biogen Idec building

Biogen/Eisai’s Alzheimer’s drug approved by MHRA but not recommended by NICE

The health technology assessment agency outlined that the drug's benefits are “too small” to justify its costs

- PMLiVE

Astellas’ Vyloy combination approved by MHRA as first-line gastric cancer treatment

Approximately 6,600 new cases of the disease are diagnosed in the UK every year

- PMLiVE

AstraZeneca’s Truqap granted MHRA approval to treat advanced breast cancer

Approximately 56,800 new cases of breast cancer are diagnosed in the UK every year

- PMLiVE

Sanofi/Regeneron’s Dupixent approved by EMA for uncontrolled COPD in adults

Approximately 220,000 COPD patients in the EU could be eligible for Dupixent treatment

- PMLiVE

Johnson & Johnson announces CHMP recommendation for Balversa in bladder cancer

Up to 20% of patients diagnosed with metastatic urothelial carcinoma have FGFR genetic alterations

tijana being interviewed

Envision Analogue – An Introduction

Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive...

Genesis Research Group

EU flag

EMA announces launch of two advice pilots to improve clinical trials in Europe

The pilots are part of the Accelerating Clinical Trials in the EU initiative to foster high-quality clinical research

- PMLiVE

AstraZeneca’s Tagrisso combination receives CHMP recommendation for advanced lung cancer

More than 450,000 people are diagnosed with lung cancer every year in Europe

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links